Cargando…
Urothelial Carcinoma With Pulmonary Tumor Thrombotic Microangiopathy After Chemotherapy for Hodgkin Lymphoma
Treatment-related second malignancies (SMs) remain a major concern in long-term survivors of Hodgkin lymphoma (HL). In this report, the autopsy findings of a patient with HL, who was in complete remission after chemotherapy but expired of pulmonary tumor thrombotic microangiopathy (PTTM) caused by u...
Autores principales: | Shimizu, Naomi, Ito, Takuro, Sato, Shuji, Sugiura, Yoshiya, Tatsuno, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451552/ https://www.ncbi.nlm.nih.gov/pubmed/36128009 http://dx.doi.org/10.14740/jocmr4802 |
Ejemplares similares
-
Pulmonary tumor thrombotic microangiopathy in a patient with a metastatic urothelial carcinoma
por: Pinto Pereira, Joao, et al.
Publicado: (2021) -
Chemotherapy-Associated Thrombotic Microangiopathy
por: Aklilu, Abinet M., et al.
Publicado: (2023) -
Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020) -
Pulmonary tumor thrombotic microangiopathy associated with urothelial carcinoma of the urinary bladder: antemortem diagnosis by pulmonary microvascular cytology
por: Yamakawa, Hideaki, et al.
Publicado: (2015) -
Pulmonary thrombotic microangiopathy caused by gastric carcinoma
por: Yokomine, Tatsuo, et al.
Publicado: (2010)